CN109265540A - 一种新型鹅星状病毒卵黄抗体的制备及其应用 - Google Patents
一种新型鹅星状病毒卵黄抗体的制备及其应用 Download PDFInfo
- Publication number
- CN109265540A CN109265540A CN201810941620.3A CN201810941620A CN109265540A CN 109265540 A CN109265540 A CN 109265540A CN 201810941620 A CN201810941620 A CN 201810941620A CN 109265540 A CN109265540 A CN 109265540A
- Authority
- CN
- China
- Prior art keywords
- antibody
- goose
- yolk
- added
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000002969 egg yolk Anatomy 0.000 title claims abstract description 36
- 241000540503 Goose astrovirus Species 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 241000272814 Anser sp. Species 0.000 claims abstract description 70
- 239000010977 jade Substances 0.000 claims abstract description 11
- 229940031551 inactivated vaccine Drugs 0.000 claims abstract description 10
- 239000000427 antigen Substances 0.000 claims abstract description 9
- 102000036639 antigens Human genes 0.000 claims abstract description 9
- 108091007433 antigens Proteins 0.000 claims abstract description 9
- 241000700605 Viruses Species 0.000 claims description 29
- 239000007788 liquid Substances 0.000 claims description 26
- 230000002779 inactivation Effects 0.000 claims description 19
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 16
- 238000011081 inoculation Methods 0.000 claims description 16
- 235000013601 eggs Nutrition 0.000 claims description 15
- 241000287828 Gallus gallus Species 0.000 claims description 14
- 238000010255 intramuscular injection Methods 0.000 claims description 13
- 239000007927 intramuscular injection Substances 0.000 claims description 13
- 230000036039 immunity Effects 0.000 claims description 12
- 241000272201 Columbiformes Species 0.000 claims description 11
- 201000005569 Gout Diseases 0.000 claims description 11
- 210000000481 breast Anatomy 0.000 claims description 11
- 238000003756 stirring Methods 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 229960005486 vaccine Drugs 0.000 claims description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 238000004321 preservation Methods 0.000 claims description 8
- 102000002322 Egg Proteins Human genes 0.000 claims description 7
- 108010000912 Egg Proteins Proteins 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 6
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- 239000008215 water for injection Substances 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 235000013345 egg yolk Nutrition 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 230000001900 immune effect Effects 0.000 claims description 4
- 238000005070 sampling Methods 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 238000000108 ultra-filtration Methods 0.000 claims description 4
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 claims description 3
- 230000020477 pH reduction Effects 0.000 claims description 3
- 238000009928 pasteurization Methods 0.000 claims description 3
- 210000002976 pectoralis muscle Anatomy 0.000 claims description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 3
- 229920000053 polysorbate 80 Polymers 0.000 claims description 3
- 238000012797 qualification Methods 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 2
- 238000012360 testing method Methods 0.000 abstract description 11
- 238000005259 measurement Methods 0.000 abstract description 5
- 238000002347 injection Methods 0.000 abstract description 4
- 239000007924 injection Substances 0.000 abstract description 4
- 206010067484 Adverse reaction Diseases 0.000 abstract description 2
- 230000006838 adverse reaction Effects 0.000 abstract description 2
- 238000011161 development Methods 0.000 abstract description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 32
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 239000002574 poison Substances 0.000 description 13
- 231100000614 poison Toxicity 0.000 description 13
- 235000013330 chicken meat Nutrition 0.000 description 12
- 201000010099 disease Diseases 0.000 description 11
- 210000002257 embryonic structure Anatomy 0.000 description 11
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 9
- 229940116269 uric acid Drugs 0.000 description 9
- 230000033558 biomineral tissue development Effects 0.000 description 8
- 241000272517 Anseriformes Species 0.000 description 7
- 206010012735 Diarrhoea Diseases 0.000 description 7
- 238000000926 separation method Methods 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 7
- 230000003612 virological effect Effects 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 238000003306 harvesting Methods 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000006386 neutralization reaction Methods 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 238000011218 seed culture Methods 0.000 description 4
- 238000010254 subcutaneous injection Methods 0.000 description 4
- 239000007929 subcutaneous injection Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 208000002979 Influenza in Birds Diseases 0.000 description 3
- 206010064097 avian influenza Diseases 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 238000002649 immunization Methods 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 210000003516 pericardium Anatomy 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 241001533384 Circovirus Species 0.000 description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 241001503699 Muscovy duck parvovirus Species 0.000 description 2
- 241001148547 Mycoplasma gallinarum Species 0.000 description 2
- 206010035148 Plague Diseases 0.000 description 2
- 241000702263 Reovirus sp. Species 0.000 description 2
- 235000011941 Tilia x europaea Nutrition 0.000 description 2
- 241000607479 Yersinia pestis Species 0.000 description 2
- 230000035508 accumulation Effects 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 244000309743 astrovirus Species 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000012631 diagnostic technique Methods 0.000 description 2
- 210000003278 egg shell Anatomy 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000004571 lime Substances 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000011265 semifinished product Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 210000000626 ureter Anatomy 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 206010049244 Ankyloglossia congenital Diseases 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000701802 Aviadenovirus Species 0.000 description 1
- 206010006100 Bradykinesia Diseases 0.000 description 1
- 241000224483 Coccidia Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010048469 Kidney enlargement Diseases 0.000 description 1
- 241001430197 Mollicutes Species 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 210000001691 amnion Anatomy 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001165 anti-coccidial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000004668 avian leukosis Diseases 0.000 description 1
- 210000002298 blastodisc Anatomy 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000003711 chorioallantoic membrane Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 235000019628 coolness Nutrition 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000000937 inactivator Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000010871 livestock manure Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 125000005473 octanoic acid group Chemical class 0.000 description 1
- 210000003250 oocyst Anatomy 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000011100 viral filtration Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Reproductive Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810941620.3A CN109265540B (zh) | 2018-08-17 | 2018-08-17 | 一种鹅星状病毒卵黄抗体的制备及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810941620.3A CN109265540B (zh) | 2018-08-17 | 2018-08-17 | 一种鹅星状病毒卵黄抗体的制备及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109265540A true CN109265540A (zh) | 2019-01-25 |
CN109265540B CN109265540B (zh) | 2021-08-20 |
Family
ID=65153728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810941620.3A Active CN109265540B (zh) | 2018-08-17 | 2018-08-17 | 一种鹅星状病毒卵黄抗体的制备及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109265540B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110590945A (zh) * | 2019-08-29 | 2019-12-20 | 广东渔跃生物技术有限公司 | 一种鸭星状病毒卵黄抗体的制备方法 |
CN111905100A (zh) * | 2020-08-17 | 2020-11-10 | 山东信得科技股份有限公司 | 一种鹅星状病毒二价灭活疫苗和卵黄抗体及其制备方法 |
CN112341539A (zh) * | 2020-10-22 | 2021-02-09 | 山东农业大学 | 防治具有跨种传播能力的新型鹅星状病毒的卵黄抗体及其制备方法 |
CN113214388A (zh) * | 2021-05-12 | 2021-08-06 | 北京世华康源生物科技有限公司 | 一种鹅星状病毒卵黄抗体及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104804084A (zh) * | 2015-05-12 | 2015-07-29 | 鲁东大学 | 一种雏鹅病毒性肝炎抗体及制备方法和应用 |
CN105949307A (zh) * | 2016-06-18 | 2016-09-21 | 青岛易邦生物工程有限公司 | 一种用于防治番鸭源小鹅瘟的卵黄抗体 |
CN105950564A (zh) * | 2016-05-03 | 2016-09-21 | 重庆三杰众鑫生物工程有限公司 | 番鸭肝炎病毒及应用该病毒制备番鸭肝炎病毒精制卵黄抗体的方法 |
-
2018
- 2018-08-17 CN CN201810941620.3A patent/CN109265540B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104804084A (zh) * | 2015-05-12 | 2015-07-29 | 鲁东大学 | 一种雏鹅病毒性肝炎抗体及制备方法和应用 |
CN105950564A (zh) * | 2016-05-03 | 2016-09-21 | 重庆三杰众鑫生物工程有限公司 | 番鸭肝炎病毒及应用该病毒制备番鸭肝炎病毒精制卵黄抗体的方法 |
CN105949307A (zh) * | 2016-06-18 | 2016-09-21 | 青岛易邦生物工程有限公司 | 一种用于防治番鸭源小鹅瘟的卵黄抗体 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110590945A (zh) * | 2019-08-29 | 2019-12-20 | 广东渔跃生物技术有限公司 | 一种鸭星状病毒卵黄抗体的制备方法 |
CN110590945B (zh) * | 2019-08-29 | 2021-06-15 | 广东渔跃生物技术有限公司 | 一种鸭星状病毒卵黄抗体的制备方法 |
CN111905100A (zh) * | 2020-08-17 | 2020-11-10 | 山东信得科技股份有限公司 | 一种鹅星状病毒二价灭活疫苗和卵黄抗体及其制备方法 |
CN112341539A (zh) * | 2020-10-22 | 2021-02-09 | 山东农业大学 | 防治具有跨种传播能力的新型鹅星状病毒的卵黄抗体及其制备方法 |
CN113214388A (zh) * | 2021-05-12 | 2021-08-06 | 北京世华康源生物科技有限公司 | 一种鹅星状病毒卵黄抗体及其制备方法 |
CN113214388B (zh) * | 2021-05-12 | 2022-06-28 | 南阳师范学院 | 一种鹅星状病毒卵黄抗体及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN109265540B (zh) | 2021-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109265540A (zh) | 一种新型鹅星状病毒卵黄抗体的制备及其应用 | |
CN109082415A (zh) | 一种新型鹅星状病毒病毒株及其应用 | |
CN108558995B (zh) | 一种防治新型鹅星状病毒的卵黄抗体及其制备方法 | |
CN111905100B (zh) | 一种鹅星状病毒二价灭活疫苗和卵黄抗体及其制备方法 | |
CN111000993B (zh) | 一种鸭病毒性肝炎、鸭呼肠孤病毒病二联灭活疫苗及其制备方法 | |
CN108794627A (zh) | 一种鸭呼肠孤病毒精制卵黄抗体的制备方法 | |
CN105949307B (zh) | 一种用于防治番鸭源小鹅瘟的卵黄抗体 | |
CN108912227B (zh) | 一种抗鸭呼肠孤病毒的卵黄抗体及其制备方法和应用 | |
CN107137704A (zh) | 一种鸭2型腺病毒灭活疫苗 | |
CN104922665A (zh) | 一种鸡新城疫、传染性支气管炎和h9亚型禽流感三联灭活疫苗 | |
CN111154730B (zh) | 一种鹅星状病毒变异毒株 | |
CN109097340B (zh) | 一种禽腺病毒、一种四联疫苗及其制备方法 | |
CN108465107B (zh) | 一种鸭2型腺病毒和番鸭细小病毒病二联灭活疫苗 | |
CN105585632A (zh) | 肉鸭细小病毒精制卵黄抗体 | |
CN108939063B (zh) | 一种番鸭三联灭活疫苗 | |
CN106065030A (zh) | 鸡包涵体肝炎的卵黄抗体及其制备方法 | |
CN111533803A (zh) | 一种番鸭腺病毒2型、3型精制卵黄抗体及其制备方法 | |
CN112999343B (zh) | 一种鹅星状病毒的灭活疫苗及其制备方法 | |
CN109762062A (zh) | 一种鹅痛风病卵黄抗体的制备方法 | |
CN112552398B (zh) | 一种鸭病毒性肝炎卵黄抗体及其制备方法 | |
CN109260467A (zh) | 一种预防雏鹅痛风症状的疫苗 | |
CN106636013A (zh) | 安卡拉病毒毒株FAdV‑HB及其灭活疫苗的制备和应用 | |
CN106075424B (zh) | 一种禽流感病毒疫苗 | |
CN110079509A (zh) | 一种Ⅰ群11d型禽腺病毒株、灭活疫苗及其制备方法 | |
CN112921006B (zh) | 一株鹅星状病毒及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation and application of goose stellate virus yolk antibody Effective date of registration: 20211222 Granted publication date: 20210820 Pledgee: Shandong Zhucheng rural commercial bank Limited by Share Ltd. Pledgor: SHANDONG SINDER TECHNOLOGY Co.,Ltd. Registration number: Y2021980015708 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20221223 Granted publication date: 20210820 Pledgee: Shandong Zhucheng rural commercial bank Limited by Share Ltd. Pledgor: SHANDONG SINDER TECHNOLOGY Co.,Ltd. Registration number: Y2021980015708 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation and Application of a Egg Yolk Antibody Against Goose Stellate Virus Effective date of registration: 20230608 Granted publication date: 20210820 Pledgee: Shandong Zhucheng rural commercial bank Limited by Share Ltd. Pledgor: SHANDONG SINDER TECHNOLOGY Co.,Ltd. Registration number: Y2023980043376 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |